Straumann Group (STMN) CMD 2025 summary

Strategic Vision and Market Opportunity

• Targets 10% CAGR revenue growth and 40–50 bps annual EBIT margin expansion from 2026–2030, aiming for double-digit market share in key segments and 10 million smiles by 2030, driven by innovation, digitalization, and operational excellence.

• Focuses on large, underpenetrated dental markets, including implantology, clear aligners, digital equipment, and prosthetics, with significant growth expected through 2030.

• Maintains strong growth in core implant business, leveraging product innovation, education, and geographic expansion, with a 35% global market share achieved by 2024.

• Digital ecosystem and cloud-based platforms (Straumann Access/AXS) are central, enabling workflow integration, AI-driven planning, and recurring revenue streams.

• Multi-brand approach, local-for-local manufacturing, and a global network enhance resilience, market reach, and natural currency hedging.

Financial Performance and Guidance

• Achieved 16.2% CAGR in net revenue (2021–2024) and 18.5% CAGR in EBIT, with EBIT margin improving to 32.4% at constant FX, outperforming prior targets.

• Financial ambition for 2030: revenue growth around 10% CAGR and 40–50 bps annual EBIT margin improvement (2026–2030, constant FX).

• FX headwinds, especially from the Swiss franc, impacted reported margins; operational measures, local production, and natural hedging aim to mitigate this.

• CapEx intensity to decrease as recent investments double production capacity; free cash flow conversion expected to rise with improved working capital management.

• No M&A included in growth guidance; organic growth prioritized, with M&A as a potential accelerator and strong cash generation to fund growth and dividends.

Business Transformation and Innovation

• Implant leadership reinforced by proprietary technologies (e.g., Roxolid, SLActive, IXL), product innovation, and education, driving premium and value segment growth.

• Digital transformation integrates AI, cloud, and open platforms, streamlining workflows and enabling new business models such as chairside prosthetics and remote monitoring.

• Ortho business transformation focuses on cost leadership, scalable manufacturing, and digital ecosystem partnerships (e.g., Smartee, DentalMonitoring), targeting significant market share gains and break-even by 2027.

• New digital equipment (Sirius X3, MIDAS by SprintRay) and partnerships (SprintRay, ThreeShape) expand the addressable market and improve gross margins.

• Education, customer-centric culture, and high employee engagement underpin execution and leadership development.